… the risk versus benefit of radioiodine treatment in patients with low-risk thyroid cancer and
of additional radioiodine therapies in patients with persistent or recurrent thyroid cancer [121]. …

… Therefore, a clinical judgment of the importance of radioiodine treatment may be even
slower in developing except in major centers. .This involves no disadvantage in the actual …

… This article presents an overview of the use of radioactive iodine (131-I) in the treatment of
patients who have well differentiated thyroid cancer. … The indications of radioiodine treatment …

… Radioactive iodine (131I) has now been used for nearly 40 years for the treatment of
hyperthyroidism and thyroid cancer. The carcinogenic hazard in relation to the treatment of …

… uptake is scintigraphically proven before therapy or after empiric RAIT, radioiodine treatment
of non-resectable or incompletely resectable tumour, eg local recurrences, lymph node …

… In order to drive RAI into remnant thyroid cells and RAI-avid thyroid cancer cells, serum TSH
must be temporarily elevated. The ATA thyroid nodules and cancer guidelines recommend …

… patients less than 40 years of age, all had metastases regress after radioiodine treatment.
One later died of thyroid cancer. In the 17 patients older than 40 years of age, with papillary …

… l treatment for ablation of residual thyroid tissue after surgical thyroidectomy, and 26 had 131
l treatment for metastatic thyroid cancer. … radiation doses to the thyroid — about 4.4 times …

… he phrase radioiodine therapy refers to the treatment of residual or recurrent thyroid cancer
within the thyroid bed and to the treatment of metastatic thyroid cancer outside the thyroid bed…

… and treatment, the two principal methods for selection of a dosage of radioiodine for ablation
and treatment … for the use of radioiodine for ablation and treatment from our professional …